Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860573 · ClinicalTrials.gov registry record · NA
Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT01860573 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 168 participants.
The verdict
NCT01860573, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmental outcomes by age 2.
Interventions
- DRUG Amino acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2008-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01860573
The ClinicalTrials.gov registry entry for NCT01860573 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amino acids is the first listed.
NCT01860573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01860573 about?
NCT01860573 is a clinical study titled "Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants". The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmental outcomes by age 2.
What is the current status of trial NCT01860573?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2008-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01860573?
The interventions under investigation include: Amino acids (DRUG).
Who is sponsoring clinical trial NCT01860573?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.